Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
129,821,091
-
Total 13F shares
-
10,850,740
-
Share change
-
-285,558
-
Total reported value
-
$17,857,140
-
Price per share
-
$1.64
-
Number of holders
-
12
-
Value change
-
-$500,485
-
Number of buys
-
3
-
Number of sells
-
17
Institutional Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q1 2024
As of 31 Mar 2024,
PROKIDNEY CORP. - Ordinary Shares (PROK) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,850,740 shares.
The largest 10 holders included
MORGAN STANLEY, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Bank of New York Mellon Corp, AMUNDI, JPMORGAN CHASE & CO, Voya Investment Management LLC, NEW YORK STATE COMMON RETIREMENT FUND, PRICE T ROWE ASSOCIATES INC /MD/, CITADEL ADVISORS LLC, and Legal & General Group Plc.
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.